ResearcherGeneral Hospital of Shenyang Military RegionNo recent work listed
Xu Liu
Matched on OpenAlex author ID A5112055406. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper
Papers 3
- Effects of KAI gene expression on ferroptosis in pancreatic cancer cells. Co-author DOI 10.3892/mmr.2020.11802↗
- Src/STAT3 signaling pathways are involved in KAI1-induced downregulation of VEGF-C expression in pancreatic cancer. Co-author DOI 10.3892/mmr.2016.5093↗
- KAI1 inhibits lymphangiogenesis and lymphatic metastasis of pancreatic cancer in vivo. Co-author DOI 10.1016/s1499-3872(14)60012-6↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hongyu Li · 3 shared papers, 2014–2021 · strength 0.30
- Paper Effects of KAI gene expression on ferroptosis in pancreatic cancer cells. DOI 10.3892/mmr.2020.11802↗
- Paper Src/STAT3 signaling pathways are involved in KAI1-induced downregulation of VEGF-C expression in pancreatic cancer. DOI 10.3892/mmr.2016.5093↗
- Paper KAI1 inhibits lymphangiogenesis and lymphatic metastasis of pancreatic cancer in vivo. DOI 10.1016/s1499-3872(14)60012-6↗
- Xiaozhong Guo · 3 shared papers, 2014–2021 · strength 0.30
- Paper Effects of KAI gene expression on ferroptosis in pancreatic cancer cells. DOI 10.3892/mmr.2020.11802↗
- Paper Src/STAT3 signaling pathways are involved in KAI1-induced downregulation of VEGF-C expression in pancreatic cancer. DOI 10.3892/mmr.2016.5093↗
- Paper KAI1 inhibits lymphangiogenesis and lymphatic metastasis of pancreatic cancer in vivo. DOI 10.1016/s1499-3872(14)60012-6↗
- Jiang Chen · 2 shared papers, 2014–2021 · strength 0.22
- Hao Han · 1 shared paper, 2021 · strength 0.17
- Xingshun Qi · 1 shared paper, 2016 · strength 0.08
- Linan Ren · 1 shared paper, 2014 · strength 0.05
- Chunyan Wu · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.